.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Deloitte
Fuji
Johnson and Johnson
Citi
Harvard Business School
Colorcon
Julphar
US Army
Chinese Patent Office
McKesson

Generated: July 26, 2017

DrugPatentWatch Database Preview

Estrogens, conjugated - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for estrogens, conjugated and what is the scope of estrogens, conjugated freedom to operate?

Estrogens, conjugated
is the generic ingredient in twelve branded drugs marketed by Wyeth Pharms Inc, Teva Womens, Teva Branded Pharm, Medpointe Pharm Hlc, and Wyeth Ayerst, and is included in ten NDAs. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for estrogens, conjugated. Eight suppliers are listed for this compound.

Summary for Generic Name: estrogens, conjugated

Tradenames:12
Patents:3
Applicants:5
NDAs:10
Drug Master File Entries: see list3
Suppliers / Packagers: see list8
Clinical Trials: see list297
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:estrogens, conjugated at DailyMed

Pharmacology for Ingredient: estrogens, conjugated

Ingredient-typeEstrogens, Conjugated (USP)
Drug ClassEstrogen
Mechanism of ActionEstrogen Receptor Agonists
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wyeth Ayerst
PMB 400
estrogens, conjugated; meprobamate
TABLET;ORAL010971-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Wyeth Pharms Inc
PREMARIN
estrogens, conjugated
TABLET;ORAL004782-001Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe► Subscribe
Wyeth Pharms Inc
PREMARIN
estrogens, conjugated
TABLET;ORAL004782-004Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe► Subscribe
Wyeth Pharms Inc
PREMARIN
estrogens, conjugated
CREAM;TOPICAL, VAGINAL020216-001Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe► Subscribe
Wyeth Pharms Inc
PREMARIN
estrogens, conjugated
TABLET;ORAL004782-003Approved Prior to Jan 1, 1982RXYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: estrogens, conjugated

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Wyeth Pharms Inc
PREMARIN
estrogens, conjugated
TABLET;ORAL004782-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Wyeth Pharms Inc
PREMARIN
estrogens, conjugated
INJECTABLE;INJECTION010402-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Wyeth Pharms Inc
PREMARIN
estrogens, conjugated
TABLET;ORAL004782-003Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Wyeth Pharms Inc
PREMARIN
estrogens, conjugated
TABLET;ORAL004782-005Jan 26, 1984► Subscribe► Subscribe
Wyeth Pharms Inc
PREMARIN
estrogens, conjugated
TABLET;ORAL004782-004Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
US Department of Justice
Accenture
Novartis
UBS
Express Scripts
Fish and Richardson
Moodys
Dow
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot